Clinical Trial Update: Lucentis Versus Mitomycin C During Glaucoma Surgery [Phase 2, Phase 3]

View source ↗

Summary

This Phase 2/3 trial compared Lucentis (ranibizumab) with mitomycin C in glaucoma surgery and has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Lucentis (ranibizumab)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Wills Eye | Conditions: Glaucoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-03-13